Polar Capital Holdings’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Polar Capital Holdings’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,299,372	Closed	-$26.2K	–	474
2021 Q3	$26.2K	Buy	1,299,372 +214,559	+20%	+$5.92M	0.11%	147
2021 Q2	$40.5K	Hold	1,084,813	–	–	0.18%	114
2021 Q1	$27.7M	Buy	+1,084,813	New	+$27.7M	0.17%	132

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Polar Capital Holdings's DRNA Position: Q4 2021 in Review

Polar Capital Holdings sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 1,299,372 shares — an estimated $26.2K sold.

Polar Capital Holdings first reported a position in DRNA in Q1 2021 and held it in 3 quarters. The position peaked at $27.7M in Q1 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Polar Capital Holdings reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Polar Capital Holdings sold 1,299,372 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $26.2K.
Polar Capital Holdings first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2021 and held it in 3 quarters.
Polar Capital Holdings's Dicerna Pharmaceuticals, Inc. position peaked at $27.7M in Q1 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Polar Capital Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.